|

Mavorixafor Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: X4P-001

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • X4 Pharmaceuticals2

Indications

  • Hepatic Insufficiency1
  • Liver Disease1
  • Heart Disease1
  • Neutropenia1

Phoenix, Arizona1 trial

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Phoenix Children's Hospital

Phase 3

Montclair, California1 trial

A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function

Catalina Research Institute, LLC

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.